TARGOCID Side Effects

5793420-4 | Blood Creatinine Increased, Blood Urea Increased, Renal Failure, Vomiting
on Jun 20, 2008 Male patient from , 75 years of age, was treated with Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, renal failure, vomiting. Targocid dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), COVERSYL /00790701/ (View Coversyl /00790701/ Review and Coversyl /00790701/ Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ELISOR (View Elisor Review and Elisor Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ). Patient was hospitalized.

5789443-1 | Aspiration Bone Marrow, Bone Marrow Failure, Erythropenia, Leukopenia, Pancytopenia, Thrombocytopenia
Patient was taking Targocid (View Usage). Patient had the following side effects: aspiration bone marrow, bone marrow failure, erythropenia, leukopenia, pancytopenia, thrombocytopenia on Feb 18, 2008 from Additional patient health information: Female patient , 77 years of age, . Targocid dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), SECTRAL (View Sectral Review and Sectral Label ), PRIMPERAN /00041901/ (View Primperan /00041901/ Review and Primperan /00041901/ Label ), AMLOR (View Amlor Review and Amlor Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ). Patient was hospitalized.

5641066-0 | Aspiration Bone Marrow, Bone Marrow Failure, Erythropenia, Leukopenia, Pancytopenia, Thrombocytopenia
Adverse event was reported on Feb 18, 2008 by a Female patient taking Targocid (View Usage) (Dosage: ) . Location: , 77 years of age, After Targocid was administered, patient had the following side effects: aspiration bone marrow, bone marrow failure, erythropenia, leukopenia, pancytopenia, thrombocytopenia. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), SECTRAL (View Sectral Review and Sectral Label ), METOCLOPRAMIDE HCL (View Metoclopramide Hcl Review and Metoclopramide Hcl Label ), AMLOR (View Amlor Review and Amlor Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ). Patient was hospitalized.

5613752-X | Leukopenia, Thrombocytopenia
on Jan 30, 2008 Male patient from SPAIN , 71 years of age, was diagnosed with prophylaxis and was treated with Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, thrombocytopenia. Targocid dosage: . During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), FLAGYL (View Flagyl Review and Flagyl Label ), TIENAM (View Tienam Review and Tienam Label ), ENANTYUM (View Enantyum Review and Enantyum Label ), OMEPRAZOL STADA (View Omeprazol Stada Review and Omeprazol Stada Label ). Patient was hospitalized.


5604279-X | Neutropenia
on Jan 21, 2008 Male patient from , 72 years of age, was treated with Targocid (View Usage). Patient had the following side effects: neutropenia. Targocid dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), CLEXANE (View Clexane Review and Clexane Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ESPIDIFEN (View Espidifen Review and Espidifen Label ), CAPOTEN (View Capoten Review and Capoten Label ), MINODIAB (View Minodiab Review and Minodiab Label ), EFFERALGAN /00020001/ (View Efferalgan /00020001/ Review and Efferalgan /00020001/ Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5595573-X | Febrile Neutropenia, Pancytopenia
Patient was taking Targocid (View Usage). After Targocid was administered, patient had the following side effects: febrile neutropenia, pancytopenia on Jan 14, 2008 from Additional patient health information: Female patient , 86 years of age, was diagnosed with endocarditis (What is endocarditis?) and. Targocid dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), DI ANTALVIC /00220901/ (View Di-antalvic /00220901/ Review and Di-antalvic /00220901/ Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5582807-0 | Blood Alkaline Phosphatase Increased, Cardiac Arrest, Gamma-glutamyltransferase Increased
Adverse event was reported on Dec 28, 2007 by a Female patient taking Targocid (View Usage) (Dosage: ) . Location: , 78 years of age, Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, cardiac arrest (What is cardiac arrest?), gamma-glutamyltransferase increased. During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

5578040-9 | Blood Alkaline Phosphatase Increased, Cardiac Arrest, Gamma-glutamyltransferase Increased
on Dec 26, 2007 Female patient from , 78 years of age, was treated with Targocid (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, cardiac arrest (What is cardiac arrest?), gamma-glutamyltransferase increased. Targocid dosage: . During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

5528360-9 | Renal Failure Acute
on Nov 20, 2007 Male patient from JAPAN , 77 years of age, weighting 100.8 lb, was diagnosed with pneumonia staphylococcal, hypertension and was treated with Targocid (View Usage). After Targocid was administered, patient had the following side effects: renal failure acute. Targocid dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DICHLOTRIDE (View Dichlotride Review and Dichlotride Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), TANATRIL (View Tanatril Review and Tanatril Label ), MECLOCELIN (View Meclocelin Review and Meclocelin Label ), SELIS (View Selis Review and Selis Label ).

5528349-X | Aspiration Bone Marrow, Bone Marrow Failure, Erythropenia, Leukopenia, Pancytopenia, Thrombocytopenia
Patient was taking Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration bone marrow, bone marrow failure, erythropenia, leukopenia, pancytopenia, thrombocytopenia on Nov 19, 2007 from Additional patient health information: Female patient , 77 years of age, was diagnosed with staphylococcal sepsis and. Targocid dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), SECTRAL (View Sectral Review and Sectral Label ), METOCLOPRAMIDE HCL (View Metoclopramide Hcl Review and Metoclopramide Hcl Label ), AMLOR (View Amlor Review and Amlor Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ). Patient was hospitalized.

5521776-6 | Meningitis, No Therapeutic Response
Adverse event was reported on Nov 15, 2007 by a Male patient taking Targocid (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?) and. Location: JAPAN , child 2 years of age, Patient had the following side effects: meningitis (What is meningitis?), no therapeutic response. During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), VICCILLIN (View Viccillin Review and Viccillin Label ), CARBENIN (View Carbenin Review and Carbenin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

5520642-X | Renal Failure Acute
on Nov 14, 2007 Male patient from JAPAN , 77 years of age, weighting 100.8 lb, was diagnosed with hypertension, pneumonia (What is pneumonia?) and was treated with Targocid (View Usage). After Targocid was administered, patient had the following side effects: renal failure acute. Targocid dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DICHLOTRIDE (View Dichlotride Review and Dichlotride Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), TANATRIL (View Tanatril Review and Tanatril Label ), MECLOCELIN (View Meclocelin Review and Meclocelin Label ), SELIS (View Selis Review and Selis Label ).

5519290-7 | Meningitis
on Nov 07, 2007 Male patient from JAPAN , child 2 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: meningitis (What is meningitis?). Targocid dosage: . During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), VICCILLIN (View Viccillin Review and Viccillin Label ), CARBENIN (View Carbenin Review and Carbenin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

5500350-1 | Renal Failure Acute
Patient was taking Targocid (View Usage). Patient had the following side effects: renal failure acute on Oct 24, 2007 from JAPAN Additional patient health information: Male patient , 77 years of age, weighting 100.8 lb, was diagnosed with hypertension, pneumonia (What is pneumonia?) and. Targocid dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DICHLOTRIDE (View Dichlotride Review and Dichlotride Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), TANATRIL (View Tanatril Review and Tanatril Label ), MECLOCELIN (View Meclocelin Review and Meclocelin Label ), SELIS (View Selis Review and Selis Label ).

5494985-2 | Leukopenia
Adverse event was reported on Oct 19, 2007 by a Male patient taking Targocid (View Usage) (Dosage: ) . Location: , 43 years of age, After Targocid was administered, patient had the following side effects: leukopenia. During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), MERONEM /01250501/ (View Meronem /01250501/ Review and Meronem /01250501/ Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), NOLOTIL /00473101/ (View Nolotil /00473101/ Review and Nolotil /00473101/ Label ). Patient was hospitalized.

5494985-2 | Leukopenia
on Oct 19, 2007 Male patient from , 43 years of age, was treated with Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia. Targocid dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), MERONEM /01250501/ (View Meronem /01250501/ Review and Meronem /01250501/ Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NOLOTIL /00473101/ (View Nolotil /00473101/ Review and Nolotil /00473101/ Label ). Patient was hospitalized.

5493578-0 | Renal Failure Acute
on Oct 18, 2007 Male patient from JAPAN , 77 years of age, weighting 100.8 lb, was diagnosed with pneumonia staphylococcal, hypertension and was treated with Targocid (View Usage). Patient had the following side effects: renal failure acute. Targocid dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DICHLOTRIDE (View Dichlotride Review and Dichlotride Label ), OLMETEC (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), TANATRIL (View Tanatril Review and Tanatril Label ), MECLOCELIN (View Meclocelin Review and Meclocelin Label ), SELIS (View Selis Review and Selis Label ).

5492327-X | Leukopenia
Patient was taking Targocid (View Usage). After Targocid was administered, patient had the following side effects: leukopenia on Oct 16, 2007 from Additional patient health information: Male patient , 43 years of age, . Targocid dosage: . During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), MERONEM /01250501/ (View Meronem /01250501/ Review and Meronem /01250501/ Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), NOLOTIL /00473101/ (View Nolotil /00473101/ Review and Nolotil /00473101/ Label ). Patient was hospitalized.

5491957-9 | Aspiration Bone Marrow, Bone Marrow Failure, Erythropenia, Leukopenia, Pancytopenia, Thrombocytopenia
Adverse event was reported on Oct 10, 2007 by a Female patient taking Targocid (View Usage) (Dosage: ) . Location: , 77 years of age, Patient experienced the following unwanted or unexpected effects: aspiration bone marrow, bone marrow failure, erythropenia, leukopenia, pancytopenia, thrombocytopenia. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), SECTRAL (View Sectral Review and Sectral Label ), PRIMPERAN /00041901/ (View Primperan /00041901/ Review and Primperan /00041901/ Label ), AMLOR (View Amlor Review and Amlor Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ). Patient was hospitalized.

5252937-1 | Uveitis
on Feb 21, 2007 Female patient from , 52 years of age, was diagnosed with candidiasis, retinitis, phlebitis and was treated with Targocid (View Usage). Patient had the following side effects: uveitis. Targocid dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PREVISCAN /00789001/ (Dose Quantity: 20; Dose Unit: Megaunits) (View Previscan /00789001/ Review and Previscan /00789001/ Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ), INSULINE (View Insuline Review and Insuline Label ). Patient was hospitalized.

5242587-5 | Hypoglycaemia, Pneumonia Staphylococcal
on Feb 15, 2007 Male patient from JAPAN , 88 years of age, was treated with Targocid (View Usage). After Targocid was administered, patient had the following side effects: hypoglycaemia, pneumonia staphylococcal. Targocid dosage: . During the same period patient was treated with GLYBURIDE (Route: Gastrostomy Tube) (View Glyburide Review and Glyburide Label ).

5239536-2 | Blood Glucose Increased, Hypoglycaemia
Patient was taking Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, hypoglycaemia on Feb 08, 2007 from JAPAN Additional patient health information: Female patient , 88 years of age, . Targocid dosage: . During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CLEANAL (View Cleanal Review and Cleanal Label ), MELBIN /00082702/ (View Melbin /00082702/ Review and Melbin /00082702/ Label ).

5121712-0 | Lymphopenia, Neutropenia
Adverse event was reported on Sep 25, 2006 by a Female patient taking Targocid (View Usage) (Dosage: ) was diagnosed with osteitis, essential hypertension and. Location: , 61 years of age, weighting 103.6 lb, Patient had the following side effects: lymphopenia, neutropenia. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), NETROMYCIN (View Netromycin Review and Netromycin Label ), VASTAREL (View Vastarel Review and Vastarel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

5007580-6 | Anaemia, Cholestasis, Leukopenia, Overdose, Pancytopenia, Renal Impairment, Subdural Haematoma, Thrombocytopenia
on May 02, 2006 Male patient from , 84 years of age, was diagnosed with device related infection, staphylococcal infection (What is staphylococcal infection?) and was treated with Targocid (View Usage). After Targocid was administered, patient had the following side effects: anaemia, cholestasis, leukopenia, overdose, pancytopenia, renal impairment, subdural haematoma, thrombocytopenia. Targocid dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), VANCOCINE (View Vancocine Review and Vancocine Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

4996426-8 | Anaemia, Leukopenia, Overdose, Pancytopenia, Subdural Haematoma, Thrombocytopenia
on May 02, 2006 Male patient from , 84 years of age, was diagnosed with arthritis bacterial, device related infection, staphylococcal infection (What is staphylococcal infection?) and was treated with Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, leukopenia, overdose, pancytopenia, subdural haematoma, thrombocytopenia. Targocid dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), VANCOCIN HCL (View Vancocin Hcl Review and Vancocin Hcl Label ).

4969250-X | Dyspnoea, Erythema
Patient was taking Targocid (View Usage). Patient had the following side effects: dyspnoea, erythema on Mar 30, 2006 from Additional patient health information: Male patient , 74 years of age, . Targocid dosage: . During the same period patient was treated with FLAGYL ^MAY^ (View Flagyl ^may^ Review and Flagyl ^may^ Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SANDOGLOBULIN (View Sandoglobulin Review and Sandoglobulin Label ), ASPEGIC 250 (View Aspegic 250 Review and Aspegic 250 Label ), MOPRAL (View Mopral Review and Mopral Label ), CALCIPARINE (View Calciparine Review and Calciparine Label ), ARANESP (View Aranesp Review and Aranesp Label ), INSULINE (View Insuline Review and Insuline Label ). Patient was hospitalized.

4917289-2 | Pustular Psoriasis
Adverse event was reported on Jun 09, 2005 by a Male patient taking Targocid (View Usage) (Dosage: ) . Location: , 62 years of age, After Targocid was administered, patient had the following side effects: pustular psoriasis. During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), LASILIX (View Lasilix Review and Lasilix Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), COVERSYL (View Coversyl Review and Coversyl Label ), SOLUPRED (View Solupred Review and Solupred Label ), MONO TILDIEM (View Mono-tildiem Review and Mono-tildiem Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4791254-0 | Pustular Psoriasis
on Jun 09, 2005 Male patient from , 62 years of age, was treated with Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: pustular psoriasis. Targocid dosage: . During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), LASILIX (View Lasilix Review and Lasilix Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), COVERSYL (View Coversyl Review and Coversyl Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4785536-6 | Cholestasis, Eosinophilia, Hypersensitivity, Rash Maculo-papular, Renal Failure
on Sep 26, 2005 Female patient from , 90 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Targocid (View Usage). Patient had the following side effects: cholestasis, eosinophilia, hypersensitivity, rash maculo-papular, renal failure. Targocid dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), RIFADIN (View Rifadin Review and Rifadin Label ), NETROMYCIN (View Netromycin Review and Netromycin Label ).

4764595-0 | Coagulopathy, Histiocytosis Haematophagic, Respiratory Failure, Thrombocytopenia
Patient was taking Targocid (View Usage). After Targocid was administered, patient had the following side effects: coagulopathy, histiocytosis haematophagic, respiratory failure, thrombocytopenia on Sep 01, 2005 from Additional patient health information: Female patient , 58 years of age, weighting 123.5 lb, . Targocid dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), CIFLOX (View Ciflox Review and Ciflox Label ), TIENAM (View Tienam Review and Tienam Label ), CANCIDAS (View Cancidas Review and Cancidas Label ). Patient was hospitalized.

4709989-4 | Anaphylactic Shock, Thrombocytopenia
Adverse event was reported on Jun 29, 2005 by a Female patient taking Targocid (View Usage) (Dosage: ) was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Location: FRANCE , 65 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, thrombocytopenia. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ).

4702972-4 | Rash Pustular
on Jun 09, 2005 Male patient from , 62 years of age, was treated with Targocid (View Usage). Patient had the following side effects: rash pustular. Targocid dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), SOLUPRED (View Solupred Review and Solupred Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLAFORAN (View Claforan Review and Claforan Label ), FLAGYL (View Flagyl Review and Flagyl Label ). Patient was hospitalized.

4702937-2 | Rash Pustular
on Jun 21, 2005 Male patient from , 62 years of age, was diagnosed with respiratory tract infection, superinfection and was treated with Targocid (View Usage). After Targocid was administered, patient had the following side effects: rash pustular. Targocid dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), SOLUPRED (View Solupred Review and Solupred Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), SURBRONC (View Surbronc Review and Surbronc Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

4696744-7 | Cardiopulmonary Failure, Leukocytosis, Myocardial Infarction, Superinfection
Patient was taking Targocid (View Usage). Patient experienced the following unwanted or unexpected effects: cardiopulmonary failure, leukocytosis, myocardial infarction, superinfection on Jun 09, 2005 from Additional patient health information: Male patient , 62 years of age, . Targocid dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), SOLUPRED (View Solupred Review and Solupred Label ), MONO TILDIEM (View Mono-tildiem Review and Mono-tildiem Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLAFORAN (View Claforan Review and Claforan Label ), FLAGYL (View Flagyl Review and Flagyl Label ). Patient was hospitalized.

4661625-1 | Anaemia, Bone Marrow Depression, Cardiac Arrest, Escherichia Infection, Haemodialysis, Neutropenia, Septic Shock, Thrombocytopenia
Adverse event was reported on Mar 03, 2005 by a Male patient taking Targocid (View Usage) (Dosage: ) was diagnosed with endocarditis bacterial, pneumonia aspiration, atrial fibrillation (What is atrial fibrillation?) and. Location: , 60 years of age, Patient had the following side effects: anaemia, bone marrow depression, cardiac arrest (What is cardiac arrest?), escherichia infection, haemodialysis, neutropenia, septic shock, thrombocytopenia. During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), NEXIUM (View Nexium Review and Nexium Label ), CORDARONE (View Cordarone Review and Cordarone Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

4563748-4 | Anaemia, Eosinophilia, Lymphadenopathy, Pyrexia, Red Blood Cell Sedimentation Rate Increased, Renal Failure
on Sep 28, 2004 Male patient from , 61 years of age, was diagnosed with endocarditis (What is endocarditis?), aortic valve disease and was treated with Targocid (View Usage). After Targocid was administered, patient had the following side effects: anaemia, eosinophilia, lymphadenopathy, pyrexia, red blood cell sedimentation rate increased, renal failure. Targocid dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.